Aptevo Therapeutics Inc (NASDAQ:APVO)’s traded shares stood at 0.13 million during the last session, with the company’s beta value hitting 5.63.The APVO share’s 52-week high
Aptevo Therapeutics Inc (NASDAQ:APVO) has a beta value of -100.00% and has seen 2.22 shares traded in the last trading session. The company, currently valued
In today’s recent session, 81.78 million shares of the Aptevo Therapeutics Inc (NASDAQ:APVO) have been traded, and its beta is 5.73. Most recently the company’s
In the last trading session, 2.04 million shares of the Aptevo Therapeutics Inc (NASDAQ:APVO) were traded, and its beta was 5.88. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne